Editorial Board Member

David Gewirtz
Department of Pharmacology and Toxicology, Virginia Commonwealth University, Richmond, VA, USA.
HomePage
Research Interests
autophagy, senescence, cancer chemotherapy, chemosensitization, radiosensitization, chemtoxicity.
Contributions:

An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer

Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/